Evaluation of Antitumoral Activity in a 3D Cell Model of a Src Inhibitor Prodrug for Glioblastoma Treatment

Evaluation of Antitumoral Activity in a 3D Cell Model of a Src Inhibitor Prodrug for Glioblastoma Treatment

<b>Background</b>: Three-dimensional (3D) cell models may bridge the gap between two-dimensional (2D) cell cultures and animal models. Technical advances have led to the development of 3D-bioprinted cell models, characterized by greater reproducibility and the ability to mimic in vivo co...

Full description

Saved in:

Bibliographic Details
Main Authors:	Letizia Clementi, Federica Poggialini, Francesca Musumeci, Julia Taglienti, Emanuele Cornacchia, Chiara Vagaggini, Anna Carbone, Giancarlo Grossi, Elena Dreassi, Adriano Angelucci, Silvia Schenone
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Pharmaceutics
Subjects:	bioprint targeted therapy tyrosine kinase pyrazolo[3,4-<i>d</i>]pyrimidines anticancer therapy
Online Access:	https://www.mdpi.com/1999-4923/17/6/704
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Halloysite Nanotube-Based Delivery of Pyrazolo[3,4-<i>d</i>]pyrimidine Derivatives for Prostate and Bladder Cancer Treatment
by: Marina Massaro, et al.
Published: (2024-11-01)

Targeting p21-activated kinase 4 (PAK4) with pyrazolo[3,4-d]pyrimidine derivative SPA7012 attenuates hepatic ischaemia-reperfusion injury in mice
by: Yuancheng Mao, et al.
Published: (2022-12-01)

Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M
by: Ahmed A. Gaber, et al.
Published: (2022-12-01)

Design, Synthesis and Molecular Modeling of Pyrazolo[1,5-<i>a</i>]pyrimidine Derivatives as Dual Inhibitors of CDK2 and TRKA Kinases with Antiproliferative Activity
by: Mohamed H. Attia, et al.
Published: (2024-12-01)

An Efficient Synthesis of 3,5-Bis-Aminated Pyrazolo[1,5-<i>a</i>]Pyrimidines: Microwave-Assisted Copper Catalyzed C-3 Amination of 5-Amino-3-Bromo-Substituted Precursors
by: Terungwa H. Iorkula, et al.
Published: (2025-01-01)

Design, theoretical approaches and new framework of pyrazolo[3,4-d]pyrimidine as potent anticancer agents: Efficient synthesis, ADME-T and molecular docking
by: Peduri Suresh Reddy, et al.
Published: (2025-03-01)

Synthesis of 1H-pyrazolo[3,4-b]pyridine analogues
by: Yen Nguyen, et al.
Published: (2025-03-01)

DEVELOPMENT OF NEW ACCESS ROUTES TO PYRAZOLO[1,5-a]PYRIMIDINE USING 4-HYDROXY-6-METHYLPYRAN-2-ONE
by: El Mokhtar Essassi, et al.
Published: (2011-02-01)

The Use of a Penta-Deuterophenyl Substituent to Improve the Metabolic Stability of a Tyrosine Kinase Inhibitor
by: Júlia Dulsat, et al.
Published: (2024-12-01)

Adaptation of the Mitsunobu Reaction for Facile Synthesis of Dorsomorphin-Based Library
by: Daria Novikova, et al.
Published: (2025-05-01)

Ionic liquid 1-butyl-3-methylimidazolium bromide: A green reaction media for the efficient synthesis of 3-methyl-1,4-diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-d]pyrimidine-6-ones/thiones using phthalimide-N-sulfonic acid as catalyst
by: S.P.N. Sudhan, et al.
Published: (2018-03-01)

Efficient Synthesis of Novel Triazolo[5,1-<i>b</i>]purines by Diacetoxyiodobenzene-Mediated Oxidative Cyclization of Schiff Bases
by: Artyom O. Neymash, et al.
Published: (2024-12-01)

Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors
by: Claudia Vergelli, et al.
Published: (2025-08-01)

Bioprintable and injectable TiO-loaded hydrogels for photothermal therapy of glioma
by: Haotian Tian, et al.
Published: (2025-06-01)

1,3-Dipolar Cycloaddition Reactions of 2-Arylmethylidentiazolo[3,2-<i>a</i>]pyrimidines with Azomethinylides: Studying the Supramolecular Organization of Products in the Crystalline Phase
by: Anna Nefedova, et al.
Published: (2024-11-01)

Establishment of in vitro Src tyrosine kinase inhibitors screening model
by: WANG Chen-hui, et al.
Published: (2007-11-01)

Synthesis of 1H-pyrazolo[1,2-b]phthalazine-5, 10-dione derivatives using Hercynite magnetic nanocatalyst
by: Zahra Paknejadi, et al.
Published: (2024-06-01)

Systematic review on the application of 3D‐bioprinting technology in orthoregeneration: current achievements and open challenges
by: Rachel L. Pan, et al.
Published: (2022-01-01)

Adaptation to climate variability and household welfare outcomes in Uganda
by: Peter Babyenda, et al.
Published: (2024-12-01)

<i>MiR-34b</i> Regulates Muscle Growth and Development by Targeting <i>SYISL</i>
by: Yuting Wu, et al.
Published: (2025-03-01)

3-Benzoyl-1′,3′,6-trimethyl-2′<i>H</i>,3<i>H</i>,4<i>H</i>-spiro[furo[3,2-<i>c</i>]pyran-2,5′-pyrimidine]-2′,4,4′,6′(1′<i>H</i>,3′<i>H</i>)-tetraone
by: Michail N. Elinson, et al.
Published: (2025-01-01)

Design, synthesis and antitumor activity of 5-trifluoromethylpyrimidine derivatives as EGFR inhibitors
by: Yaqing Zuo, et al.
Published: (2022-12-01)

Study of the Anti-klebsiella Activity of Quinazoline Compounds Containing a Piperazine Ring
by: A. A. Tsibizova, et al.
Published: (2024-11-01)

New Paradigm in Treating Cancer: Right on Target
by: Noorwati Sutandyo
Published: (2016-09-01)

New Paradigm in Treating Cancer: Right on Target
by: Noorwati Sutandyo
Published: (2016-09-01)

Mechanisms of impaired expression of p53-responsive microRNA genes in diffuse B-large cell lymphoma
by: E. N. Voropaeva, et al.
Published: (2023-10-01)

Tissue Engineering and Regenerative Medicine: Perspectives and Challenges
by: Van T. Hoang, et al.
Published: (2025-05-01)

Quantum chemistry modeling of the unimolecular decomposition mechanism and substituent effects of pyrazolo-tetrazine: A case study of BITE-101
by: Zi-xuan Yang, et al.
Published: (2025-03-01)

A concise synthesis of pyrrolo[2,3-d]pyrimidine through I2/DMSO promoted cascade annulation
by: Meng Xia, et al.
Published: (2025-08-01)

T330M Substitution in the Sodium-Dependent Phosphate Transporter NaPi2b Abolishes the Efficacy of Monoclonal Antibodies Against MX35 Epitope
by: Leisan F. Bulatova, et al.
Published: (2025-04-01)

Structural activity of synthesized pyrimidine-thiophene and pyrimidine-thiadiazole conjugates as anticancer agents
by: Abeer Mogadem, et al.
Published: (2024-10-01)

Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Novel Thiazoles, Pyrazoles, 1,3-Thiazepinones, and 1,2,4-Triazolopyrimidines Derived from Quinoline-Pyrido[2,3-<i>d</i>] Pyrimidinones
by: Ameen Ali Abu-Hashem, et al.
Published: (2024-12-01)

Multicomponent, Solvent-Free Synthesis of 4-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidines Derivatives
by: Fatima Belhadj, et al.
Published: (2023-11-01)

Using In Silico Methods to Identify Protein Tyrosine Kinase A (PtkA) Homolog in Non-Tuberculous Mycobacteria (NTM)
by: Swati Jaiswal, et al.
Published: (2024-11-01)

Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions
by: Simona Iacob (Ciobotaru), et al.
Published: (2025-06-01)

3D BIOPRINTING IN DENTISTRY: BIBLIOMETRIC ANALYSIS
by: Peter Frantsevich Litvitskiy, et al.
Published: (2024-12-01)

Polymeric hydrogels for bioprinting: A comprehensive review
by: Mohammad Amir Qureshi, et al.
Published: (2025-05-01)

The Antiviral and Antimalarial Prodrug Artemisinin from the <i>Artemisia</i> Species: A Review
by: Gitishree Das, et al.
Published: (2024-10-01)

Potentiometric Determination of Acidity Constants of Some Synthesized Organic Compounds in Organic-Water Media
by: Sh. Baluja, et al.
Published: (2016-11-01)

AXL and SRC in clear cell renal cell carcinoma: absence of mutations, rare alternative splicing events, but association of protein expression with poor prognosis
by: Muriel D Brada, et al.
Published: (2025-05-01)